Moderna (MRNA) Q3 2024 Earnings Call Transcript

Call Start: 08:00 January 1, 0000 9:00 AM ET

Moderna Inc. (NASDAQ:MRNA)
Q3 2024 Earnings Conference Call
November 7, 2024 8:00 am ET

Company Participants

Stéphane Bancel - Chief Executive Officer
Stephen Hoge - President
Jamey Mock - Chief Financial Officer
Lavina Talukdar - Senior Vice President, Investor Relations

Conference Call Participants

Salveen Richter - Goldman Sachs
Eli Merle - UBS
Gena Wang - Barclays
Michael Yee - Jefferies
Tyler Van Buren - TD Cowen
Terence Flynn - Morgan Stanley
Evan Wang - Guggenheim
Edward Tenthoff - Piper Sandler
Luca Issi - RBC Capital
Courtney Breen - Bernstein
Manos Mastorakis - Deutsche Bank

Operator

Good day and thank you for standing by. Welcome to the Moderna third quarter 2024 conference call.

At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question and answer session. To ask a question during this session, you will need to press star-one-one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star-one-one again.

Please be advised today’s conference is being recorded.

I would now like to hand the conference over to your speaker today, Lavina Talukdar. Please go ahead.

Lavina Talukdar

Thank you Kevin. Good morning everyone and thank you for joining us on today’s call to discuss Moderna’s third quarter 2024 financial results and business update.

You can access the press release issued this morning, as well as the slides that we will be reviewing, by going to the Investors section of our website.

On today’s call are Stéphane Bancel, our Chief Executive Officer, Stephen Hoge, our President, and Jamey Mock, our Chief Financial Officer.

Before we begin, please note that this conference call will include forward-looking statements made pursuant to the Safe Harbor